| m September 2004 took pharmaceutical enormous Merck backvoluntarily its painkilling medication Vioxx of the market. Studiesshow that Vioxx increases the danger of the heart attack and vioxx claim noticeamong patients, who used the drug for longer than 18 months. Vioxx, adrug of a family not Steroidanti inflammatory of the drugs, whichadmits COX-2 as obstacles is, is one only some drugs, which arespecifically sketched, around inflammation, with the avoidance of thestomach disturbances to lower long with others anti- inflammatorymedications connected. Since its introduction 1999, Vioxx was a verylarge success, and vioxx claim sales of the drug world-wide exceeded $2,5 billion2003. That is certainly much money, but it pales, if it is comparedwith the quantity, the Merck stands to umwerben in order to lose byZuverlaesslichkeit from product process to, soon comes. Starting fromthis letter some thousand processes were national arranged, butattorneys estimate that varying 100,000 reaches the total number thearranged processes koennte. Hundert thousand processes iscertainly an impressing number, but this illustration could representonly half of the number to the processes, which were referred onobstacles COX-2. Early this year, Pfizer took voluntarily its similarmedication Bextra of the market, when studies back, which withincreased heart attack was connected to the use Bextra danger and vioxx claim witha rare Hautstoerung, which admits syndrome as Stevens Johnson is.Bextra, another drug in the family of the obstacles COX-2, the workvery similarly to Vioxx and vioxx claim many patients, who took in former timesVioxx, squints to Bextra, after the former was removed from the marketin the last autumn. Assumed, sales from Bextra to close Vioxx rose,smooth, before it was removed from the market, it probably seem thatthe number processes arranged by patients, who state by its use Bextrahave been damaged could the number of Vioxx processes finallyentsprechen. Es was the courts them into straight somecategory activity complaints to combine, could the 200,000 possibleprocesses, which descend problems with Bextra and vioxx claim Vioxx our courts forthe following decade cripple. Patients, who believe that they can havebeen damaged by the use either Bextra or Vioxx, will wellguessed/advised to associate with an attorney that specialized inpharmaceutical processes as soon as possible. The waiting period for adissolution with court, particularly for Vioxx of processes, could bea very long. Those, which arrange fast, know the fastest resultserhalten. |